Logo image of JCSE

JE CLEANTECH HOLDINGS LTD (JCSE) Stock Fundamental Analysis

USA - NASDAQ:JCSE - KYG508752055 - Common Stock

1.1297 USD
-0.01 (-0.9%)
Last: 9/15/2025, 8:09:11 PM
1.1 USD
-0.03 (-2.63%)
After Hours: 9/15/2025, 8:09:11 PM
Fundamental Rating

2

Overall JCSE gets a fundamental rating of 2 out of 10. We evaluated JCSE against 128 industry peers in the Machinery industry. Both the profitability and financial health of JCSE have multiple concerns. JCSE has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

JCSE had positive earnings in the past year.
JCSE had a positive operating cash flow in the past year.
Of the past 5 years JCSE 4 years were profitable.
Of the past 5 years JCSE 4 years had a positive operating cash flow.
JCSE Yearly Net Income VS EBIT VS OCF VS FCFJCSE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 2M -2M -4M -6M

1.2 Ratios

JCSE's Return On Assets of 0.09% is on the low side compared to the rest of the industry. JCSE is outperformed by 68.75% of its industry peers.
With a Return On Equity value of 0.19%, JCSE is not doing good in the industry: 67.97% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA 0.09%
ROE 0.19%
ROIC N/A
ROA(3y)1.64%
ROA(5y)2.57%
ROE(3y)3.54%
ROE(5y)7.94%
ROIC(3y)N/A
ROIC(5y)N/A
JCSE Yearly ROA, ROE, ROICJCSE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 5 10 15 20 25

1.3 Margins

Looking at the Profit Margin, with a value of 0.17%, JCSE is doing worse than 67.97% of the companies in the same industry.
In the last couple of years the Profit Margin of JCSE has declined.
Looking at the Gross Margin, with a value of 26.94%, JCSE is doing worse than 60.16% of the companies in the same industry.
JCSE's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 0.17%
GM 26.94%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y-38.37%
GM growth 3Y19.16%
GM growth 5Y-0.17%
JCSE Yearly Profit, Operating, Gross MarginsJCSE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 5 10 15 20 25

More info and screens

3

2. Health

2.1 Basic Checks

JCSE does not have a ROIC to compare to the WACC, probably because it is not profitable.
JCSE has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, JCSE has more shares outstanding
Compared to 1 year ago, JCSE has a worse debt to assets ratio.
JCSE Yearly Shares OutstandingJCSE Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M
JCSE Yearly Total Debt VS Total AssetsJCSE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

JCSE has an Altman-Z score of 1.38. This is a bad value and indicates that JCSE is not financially healthy and even has some risk of bankruptcy.
JCSE's Altman-Z score of 1.38 is on the low side compared to the rest of the industry. JCSE is outperformed by 76.56% of its industry peers.
JCSE has a debt to FCF ratio of 10.99. This is a negative value and a sign of low solvency as JCSE would need 10.99 years to pay back of all of its debts.
The Debt to FCF ratio of JCSE (10.99) is worse than 63.28% of its industry peers.
A Debt/Equity ratio of 0.45 indicates that JCSE is not too dependend on debt financing.
JCSE has a Debt to Equity ratio (0.45) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 10.99
Altman-Z 1.38
ROIC/WACCN/A
WACC9.36%
JCSE Yearly LT Debt VS Equity VS FCFJCSE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M

2.3 Liquidity

JCSE has a Current Ratio of 2.55. This indicates that JCSE is financially healthy and has no problem in meeting its short term obligations.
JCSE has a Current ratio of 2.55. This is in the better half of the industry: JCSE outperforms 66.41% of its industry peers.
JCSE has a Quick Ratio of 1.29. This is a normal value and indicates that JCSE is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.29, JCSE is in line with its industry, outperforming 54.69% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.55
Quick Ratio 1.29
JCSE Yearly Current Assets VS Current LiabilitesJCSE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for JCSE have decreased strongly by -89.96% in the last year.
Measured over the past years, JCSE shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -38.22% on average per year.
JCSE shows a small growth in Revenue. In the last year, the Revenue has grown by 6.92%.
Measured over the past years, JCSE shows a small growth in Revenue. The Revenue has been growing by 1.14% on average per year.
EPS 1Y (TTM)-89.96%
EPS 3YN/A
EPS 5Y-38.22%
EPS Q2Q%-327.56%
Revenue 1Y (TTM)6.92%
Revenue growth 3Y9.31%
Revenue growth 5Y1.14%
Sales Q2Q%-7.39%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
JCSE Yearly Revenue VS EstimatesJCSE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 112.97 indicates a quite expensive valuation of JCSE.
JCSE's Price/Earnings ratio is a bit more expensive when compared to the industry. JCSE is more expensive than 72.66% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.27. JCSE is valued rather expensively when compared to this.
Industry RankSector Rank
PE 112.97
Fwd PE N/A
JCSE Price Earnings VS Forward Price EarningsJCSE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

71.09% of the companies in the same industry are more expensive than JCSE, based on the Enterprise Value to EBITDA ratio.
94.53% of the companies in the same industry are more expensive than JCSE, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 9.63
EV/EBITDA 11.39
JCSE Per share dataJCSE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 7.14%, JCSE is a good candidate for dividend investing.
JCSE's Dividend Yield is rather good when compared to the industry average which is at 1.74. JCSE pays more dividend than 99.22% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.38, JCSE pays a better dividend.
Industry RankSector Rank
Dividend Yield 7.14%

5.2 History

JCSE is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
JCSE Yearly Dividends per shareJCSE Yearly Dividends per shareYearly Dividends per share 2024 0.02 0.04 0.06 0.08

5.3 Sustainability

JCSE pays out 2009.38% of its income as dividend. This is not a sustainable payout ratio.
DP2009.38%
EPS Next 2YN/A
EPS Next 3YN/A
JCSE Yearly Income VS Free CF VS DividendJCSE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 0 2M -2M -4M -6M
JCSE Dividend Payout.JCSE Dividend Payout, showing the Payout Ratio.JCSE Dividend Payout.PayoutRetained Earnings

More info and screens

JE CLEANTECH HOLDINGS LTD

NASDAQ:JCSE (9/15/2025, 8:09:11 PM)

After market: 1.1 -0.03 (-2.63%)

1.1297

-0.01 (-0.9%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)09-27 2022-09-27/bmo
Earnings (Next)N/A N/A
Inst Owners0.96%
Inst Owner ChangeN/A
Ins Owners5.65%
Ins Owner ChangeN/A
Market Cap6.00M
AnalystsN/A
Price TargetN/A
Short Float %0.36%
Short Ratio0.23
Dividend
Industry RankSector Rank
Dividend Yield 7.14%
Yearly Dividend0.1
Dividend Growth(5Y)N/A
DP2009.38%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 112.97
Fwd PE N/A
P/S 0.4
P/FCF 9.63
P/OCF 3.75
P/B 0.47
P/tB 0.47
EV/EBITDA 11.39
EPS(TTM)0.01
EY0.89%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.12
FCFY10.39%
OCF(TTM)0.3
OCFY26.66%
SpS2.83
BVpS2.42
TBVpS2.42
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.09%
ROE 0.19%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 0.17%
GM 26.94%
FCFM 4.15%
ROA(3y)1.64%
ROA(5y)2.57%
ROE(3y)3.54%
ROE(5y)7.94%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y-38.37%
GM growth 3Y19.16%
GM growth 5Y-0.17%
F-Score7
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 10.99
Debt/EBITDA 7.86
Cap/Depr 127.86%
Cap/Sales 6.5%
Interest Coverage N/A
Cash Conversion 216.11%
Profit Quality 2500%
Current Ratio 2.55
Quick Ratio 1.29
Altman-Z 1.38
F-Score7
WACC9.36%
ROIC/WACCN/A
Cap/Depr(3y)93.43%
Cap/Depr(5y)89.23%
Cap/Sales(3y)4.02%
Cap/Sales(5y)3.75%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-89.96%
EPS 3YN/A
EPS 5Y-38.22%
EPS Q2Q%-327.56%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6.92%
Revenue growth 3Y9.31%
Revenue growth 5Y1.14%
Sales Q2Q%-7.39%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-102.97%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-31.27%
FCF growth 3Y-32.32%
FCF growth 5Y-2.97%
OCF growth 1Y49.31%
OCF growth 3Y-15.23%
OCF growth 5Y5.78%